47 results match your criteria: "New Jersey Medical School University Hospital[Affiliation]"
J Clin Gastroenterol
December 2024
Division of Digestive Diseases and Nutrition, Department of Internal Medicine, University of South Florida Health.
Background: Several clinical practice guidelines (CPGs) exist for managing Barrett's esophagus (BE). However, the methodological quality of these CPGs is not known. To summarize the methodological quality of CPGs, we performed a critical appraisal of all available CPGs for the management of BE published from January 2018 to February 2023.
View Article and Find Full Text PDFTurk J Gastroenterol
June 2024
Department of Internal Medicine, Hacettepe University Medical Faculty, Ankara, Türkiye.
Cite this article as: Balaban YH, Ismail M, Nur Ayar Ş. Selective immunoglobulin M deficiency in patients with autoimmune liver diseases. Turk J Gastroenterol.
View Article and Find Full Text PDFGastroenterol Hepatol (N Y)
December 2023
Department of Transplantation, Mayo Clinic, Jacksonville, Florida.
Decompensated cirrhosis, defined by the overt manifestations of liver failure and portal hypertension (eg, ascites, hepatic encephalopathy, variceal bleeding), is the inflection point associated with increased morbidity and mortality in chronic liver disease. Acute kidney injury in the setting of cirrhosis (hepatorenal syndrome-acute kidney injury [HRS-AKI]) is a severe and often fatal complication. The goals of treatment of HRS-AKI are to reverse renal failure and prolong survival in these critically ill patients or perhaps to allow the transplant team to complete the pretransplant evaluation and bridge the patient to transplant.
View Article and Find Full Text PDFACG Case Rep J
February 2024
Department of Hematology and Oncology, Saint Barnabas Medical Center, NJ.
This case study describes an instance of primary hepatic diffuse large B cell lymphoma (DLBCL) in a patient who had prolonged coronavirus disease 2019 (COVID-19). DLBCL rarely presents as a primary hepatic mass. The 53-year-old man sought emergency care because of fatigue and weight loss.
View Article and Find Full Text PDFHepatol Commun
January 2023
Mallinckrodt Pharmaceuticals, Clinton, New Jersey, USA.
Hepatorenal syndrome type 1 (HRS-1) is a serious complication of advanced cirrhosis and a potentially reversible form of acute kidney injury that is associated with rapidly deteriorating kidney function. Liver transplantation remains the only curative treatment for decompensated cirrhosis. However, terlipressin, a vasopressin analog, successfully reverses HRS-1, and may improve patient survival while awaiting liver transplantation.
View Article and Find Full Text PDFRadiol Case Rep
December 2022
Department of Radiology, Rutgers New Jersey Medical School University Hospital, 150 Bergen Street, Newark, NJ 07103, USA.
We present a case of a vascular ring formed by the left brachiocephalic vein. A left brachiocephalic vein ring or circum-aortic left brachiocephalic vein is a rare congenital vascular variant. Although it is usually an incidental finding on chest imaging studies, left brachiocephalic vein anomalies, particularly the ring variant, can be clinically significant during procedures requiring installation of transvenous implantable devices such as pacemakers.
View Article and Find Full Text PDFAnn Surg
November 2022
Department of Surgery and Transplantation, University Hospital Zurich, Zurich, Switzerland.
MedEdPORTAL
January 2019
Professor of Emergency Medicine, Rutgers New Jersey Medical School/University Hospital-Newark; Associate Dean of Education, Rutgers New Jersey Medical School/University Hospital-Newark.
Introduction: Demand that health centers address health inequities has led medical schools to emphasize social determinants of health (SDH). The Emergency Department often serves as first (or sole) point of health care access, making it an ideal environment in which to identify/explore SDH. Yet there are few SDH curricula targeting core emergency medicine (EM) clerkships.
View Article and Find Full Text PDFMol Cell Biol
February 2018
Department of Biochemistry & Molecular Biology, New Jersey Medical School, UMDNJ, Newark, New Jersey, USA
The transcription factor interferon regulatory factor 5 (IRF5) exerts crucial functions in the regulation of host immunity against extracellular pathogens, DNA damage-induced apoptosis, death receptor signaling, and macrophage polarization. Tight regulation of IRF5 is thus warranted for an efficient response to extracellular stressors and for limiting autoimmune and inflammatory responses. Here we report that the COP9 signalosome (CSN), a general modulator of diverse cellular and developmental processes, associates constitutively with IRF5 and promotes its protein stability.
View Article and Find Full Text PDFMol Cell Biol
December 2017
Department of Biochemistry & Molecular Biology, New Jersey Medical School, UMDNJ, Newark, New Jersey, USA; New Jersey Medical School-University Hospital Cancer Center, UMDNJ, Newark, New Jersey, USA.
J Hepatocell Carcinoma
August 2017
Oncovir, Washington, DC, USA.
Purpose: To determine the safety of an approach to immunologically enhance local treatment of hepatocellular cancer (HCC) by combining nonlethal radiation, local regional therapy with intratumoral injection, and systemic administration of a potent Toll-like receptor (TLR) immune adjuvant.
Methods: Patients with HCC not eligible for liver transplant or surgery were subject to: 1) 3 fractions of 2-Gy focal nonlethal radiation to increase tumor antigen expression, 2) intra-/peri-tumoral (IT) injection of the TLR3 agonist, polyinosinic-polycytidylic acid polylysine carboxymethylcellulose (poly-ICLC), to induce an immunologic "danger" response in the tumor microenvironment with local regional therapy, and 3) systemic boosting of immunity with intramuscular poly-ICLC. Primary end points were safety and tolerability; secondary end points were progression-free survival (PFS) and overall survival (OS) at 6 months, 1 year, and 2 years.
J Clin Oncol
July 2017
Jennifer Griggs, University of Michigan, Ann Arbor, MI; Shail Maingi, New Jersey Medical School-University Hospital Cancer Center, Newark, NJ; Victoria Blinder and Larry Norton, Memorial Sloan Kettering Cancer Center, New York, NY; Neelima Denduluri, US Oncology, The Woodlands, TX; Alok A. Khorana, Cleveland Clinic, Cleveland, OH; Michael Francisco and Dana S. Wollins, American Society of Clinical Oncology, Alexandria, VA; and Julia H. Rowland, National Cancer Institute, Bethesda, MD.
ASCO is committed to addressing the needs of sexual and gender minority (SGM) populations as a diverse group at risk for receiving disparate care and having suboptimal experiences, including discrimination, throughout the cancer care continuum. This position statement outlines five areas of recommendations to address the needs of both SGM populations affected by cancer and members of the oncology workforce who identify as SGM: (1) patient education and support; (2) workforce development and diversity; (3) quality improvement strategies; (4) policy solutions; and (5) research strategies. In making these recommendations, the Society calls for increased outreach and educational support for SGM patients; increased SGM cultural competency training for providers; improvement of quality-of-care metrics that include sexual orientation and gender information variables; and increased data collection to inform future work addressing the needs of SGM communities.
View Article and Find Full Text PDFEur J Gastroenterol Hepatol
November 2015
aDepartment of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, New York City, New York bDepartment of Medicine, Division of Gastroenterology and Hepatology, Rutgers Robert Wood Johnson Medical School/Saint Peters University Hospital, New Brunswick cDepartment of Medicine, Division of Gastroenterology and Hepatology, Rutgers New Jersey Medical School/University Hospital, Newark, New Jersey, USA.
Observational studies suggest that nonalcoholic fatty liver disease (NAFLD) is associated with increased carotid intimal medial thickness (C-IMT) and carotid plaques in both children and adults. We carried out a meta-analysis to evaluate the relationship between NAFLD and carotid atherosclerosis measured as C-IMT and carotid plaque prevalence. Medline (Ovid), PubMed, Web of Science, and CINAHL databases were searched from 1946 to September 2014, complemented with a manual review of references of the published articles for studies that compared C-IMT or carotid plaque prevalence in adults and children.
View Article and Find Full Text PDFJ Emerg Med
June 2015
Department of Emergency Medicine, Emory University School of Medicine, Atlanta, Georgia.
Background: Emergency medicine (EM) is commonly introduced in the fourth year of medical school because of a perceived need to have more experienced students in the complex and dynamic environment of the emergency department. However, there is no evidence supporting the optimal time or duration for an EM rotation, and a number of institutions offer third-year rotations.
Objective: A recently published syllabus provides areas of knowledge, skills, and attitudes that third-year EM rotation directors can use to develop curricula.
Am J Perinatol
February 2015
Department of Obstetrics, Gynecology, and Women's Health, Rutgers, New Jersey Medical School/University Hospital, Newark, New Jersey.
Objective: The aim of the article is to evaluate and compare labor outcomes in obese patients undergoing induction of labor (IOL) with misoprostol and dinoprostone.
Study Design: This was a retrospective review of patients who delivered from February 1, 2008, to July 1, 2013 at our institution. All obese women who underwent IOL were identified.
Blood Cancer J
August 2013
New Jersey Medical School - University Hospital Cancer Center, University of Medicine and Dentistry of New Jersey, Newark, NJ, USA.
Previous studies have demonstrated that p210 BCR/ABL1 interacts directly with the xeroderma pigmentosum group B (XPB) protein, and that XPB is phosphorylated on tyrosine in cells that express p210 BCR/ABL1. In the current study, we have constructed a p210 BCR/ABL1 mutant that can no longer bind to XPB. The mutant has normal kinase activity and interacts with GRB2, but can no longer phosphorylate XPB.
View Article and Find Full Text PDFBlood
September 2013
Department of Microbiology and Molecular Genetics and New Jersey Medical School-University Hospital Cancer Center, University of Medicine and Dentistry of New Jersey, Newark, NJ.
We have identified a ubiquitin-binding domain within the NH2-terminal sequences of p210 BCR/ABL and determined that the binding site co-localizes with the binding site for β-catenin. The domain does not support the auto- or trans-kinase activity of p210 BCR/ABL or its ability to interact with GRB2 and activate ERK1/2 signaling. Expression of p210 BCR/ABL, but not a β-catenin-binding mutant, in hematopoietic cells is associated with the accumulation of p-β-catenin (Tyr654) and increased TCF/LEF-mediated transcription.
View Article and Find Full Text PDFOncogene
June 2014
1] Department of Biochemistry and Molecular Biology, New Jersey Medical School, UMDNJ, Newark, NJ, USA [2] New Jersey Medical School-University Hospital Cancer Center, UMDNJ, Newark, NJ, USA.
Repeated low-dose γ-irradiation (IR) induces thymic lymphoma in mice because of oncogenic mutations propagating from a primitive hematopoietic stem/progenitor cell (HSC) in the bone marrow. It is well known that IR-induced thymic lymphomagenesis is markedly enhanced by p53 deficiency, yet data also indicate that p53-dependent apoptosis can actively drive tumor formation in this model. The latter was recently expounded on by findings from Puma-deficient mice, indicating that loss of this proapoptotic p53 target gene results in protection from IR-induced lymphomagenesis rather than enhanced susceptibility to.
View Article and Find Full Text PDFJ Oncol Pract
March 2013
University of Medicine and Dentistry of New Jersey, New Jersey Medical School-University Hospital Cancer Center, Newark, NJ, USA.
The Minority-Based Community Clinical Oncology Program (MB-CCOP) at University of Medicine and Dentistry of New Jersey, New Jersey Medical School-University Hospital Cancer Center was established to serve an unmet need in a medically, educationally, and socioeconomically underserved community of primarily African American and Latino patients in Newark and Essex County, New Jersey. The MB-CCOP was built on an existing infrastructure of multidisciplinary teams of cancer specialists who collaborated in patient care and an existing clinical research program, which included multilingual staff and a breast cancer navigator. This article highlights some of the unique opportunities and challenges involved in the startup of an MB-CCOP specifically relevant to an academic setting.
View Article and Find Full Text PDFTransl Stroke Res
April 2013
UMDNJ - New Jersey Medical School, Department of Neurology & Neurosciences, University Hospital Cancer Center, Newark, NJ 07103 ; UMDNJ - Graduate School Biomedical Sciences, University Hospital Cancer Center, Newark, NJ 07103 ; New Jersey Medical School University Hospital Cancer Center, Newark, NJ 07103.
Episodes of neonatal hypoxia-ischemia (H-I) are strongly associated with cerebral palsy and a wide spectrum of other neurological deficits in children. Two key processes required to repair damaged organs are to amplify the number of precursors capable of regenerating damaged cells and to direct their differentiation towards the cell types that need to be replaced. Since hypoxia induces vascular endothelial growth factor (VEGF) production, it is logical to predict that VEGFs are key mediators of tissue repair after H-I injury.
View Article and Find Full Text PDFPLoS One
July 2013
Department of Biochemistry & Molecular Biology, New Jersey Medical School, and New Jersey Medical School-University Hospital Cancer Center, UMDNJ, Newark, New Jersey, USA.
Polymorphisms in the interferon regulatory factor 5 (IRF5) gene have been consistently replicated and shown to confer risk for or protection from the development of systemic lupus erythematosus (SLE). IRF5 expression is significantly upregulated in SLE patients and upregulation associates with IRF5-SLE risk haplotypes. IRF5 alternative splicing has also been shown to be elevated in SLE patients.
View Article and Find Full Text PDFCancer Res
April 2013
Department of Orthopaedics, New Jersey Medical School-University Hospital Cancer Center, UMDNJ, Newark, NJ 07103, USA.
The retinoblastoma tumor suppressor protein pRB is conventionally regarded as an inhibitor of the E2F family of transcription factors. Conversely, pRB is also recognized as an activator of tissue-specific gene expression along various lineages including osteoblastogenesis. During osteoblast differentiation, pRB directly targets Alpl and Bglap, which encode the major markers of osteogenesis alkaline phosphatase and osteocalcin.
View Article and Find Full Text PDFMol Cell Biol
March 2013
Department of Biochemistry & Molecular Biology, New Jersey Medical School, New Jersey Medical School-University Hospital CancerCenter, UMDNJ, Newark, New Jersey, USA.
The transcription factor interferon regulatory factor 5 (IRF5) exerts crucial functions in the regulation of host immunity against extracellular pathogens, DNA damage-induced apoptosis, death receptor signaling, and macrophage polarization. Tight regulation of IRF5 is thus warranted for an efficient response toward extracellular stressors and for limiting autoimmune and inflammatory responses. Here we report that the COP9 signalosome (CSN), a general modulator of diverse cellular and developmental processes, associates constitutively with IRF5 and promotes its protein stability.
View Article and Find Full Text PDFLeukemia
April 2013
New Jersey Medical School-University Hospital Cancer Center, University of Medicine and Dentistry of New Jersey, Newark, NJ, USA.
We have previously identified a tyrosine kinase-independent, guanine nucleotide exchange factor (GEF) activity, which is contained within the region of p210 no expansion BCR/ABL that distinguishes it from p190 BCR/ABL. In the current study, we have compared the transforming activity of p190 BCR/ABL, p210 BCR/ABL and a mutant that lacks GEF activity (p210 BCR/ABL(S509A)). In cell-based, ex vivo, and murine bone marrow transplantation (BMT) assays the transforming activity of p210 BCR/ABL(S509A) mimics p190 BCR/ABL, and is distinct from p210 BCR/ABL.
View Article and Find Full Text PDF